Kraft Heinz
KHC
$22.47
+2.00%
The Kraft Heinz Company is a leading global food and beverage manufacturer, operating in the packaged foods industry with a portfolio of iconic brands including Kraft, Heinz, Oscar Mayer, Velveeta, and Philadelphia. The company is a dominant player in the North American market, leveraging its vast distribution network and significant retail presence, though it faces the classic challenges of a mature, slow-growth consumer staples business. The current investor narrative is dominated by questions around its strategic direction and ownership stability, particularly with speculation that Berkshire Hathaway's new CEO may be reconsidering its large, long-held stake, which casts a shadow over the stock and underscores ongoing debates about the company's ability to execute a meaningful turnaround in a competitive landscape.…
KHC
Kraft Heinz
$22.47
Related headlines
Investment Opinion: Should I buy KHC Today?
Rating & Thesis: The synthesized recommendation is Hold. The core thesis is that KHC is a financially stable but growth-challenged company trading at a fair valuation that reflects its muted prospects, offering a high dividend yield for income-oriented investors but lacking catalysts for significant capital appreciation. This aligns with the analyst consensus of neutral to bearish 'Hold' ratings.
Supporting Evidence: The Hold rating is supported by four key data points. First, valuation is low but arguably fair: a PS ratio of 1.15x and a forward P/E of 10.9x are appropriate for a company with negative revenue growth. Second, profitability is mixed: the latest quarter showed a net margin of 10.25%, but TTM figures are deeply negative. Third, cash flow is a clear strength, with $3.66B in TTM FCF supporting the 6.6% dividend. Fourth, the stock price is in a defined range, sitting 22% above its 52-week low and 22% below its high, indicating a lack of directional conviction.
Risks & Conditions: The two biggest risks are a further revenue decline accelerating beyond current levels and a potential sale of Berkshire Hathaway's stake triggering a sentiment-driven selloff. This Hold would upgrade to a Buy if the PS ratio compressed further toward 1.0x while quarterly revenue stabilizes or turns positive, or if a clear strategic pivot reignites growth. It would downgrade to a Sell if revenue growth decelerates further below -5% YoY, the dividend yield becomes unsustainable (payout ratio turns highly negative), or the stock breaks decisively below the $21 support level. The stock is currently fairly valued relative to its challenged fundamentals but undervalued on a historical basis.
Sign up to view all
KHC 12-Month Price Forecast
KHC presents a classic 'value vs. value trap' dilemma. The neutral stance reflects the offsetting forces of compelling cash generation and a deeply discounted valuation against a backdrop of no growth and negative sentiment. The high dividend yield of 6.6% provides a tangible return while investors wait for a turnaround, but the lack of revenue catalysts and ownership overhang cap upside potential. The base case of range-bound trading is most probable. The stance would upgrade to bullish on evidence of sustainable revenue growth (>1% YoY) or a decisive break above the $25 resistance level. It would turn bearish on a break below the $21 support or a material reduction in free cash flow generation.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Kraft Heinz's 12-month outlook, with a consensus price target around $29.21 and implied upside of +30.0% versus the current price.
Average Target
$29.21
11 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
11
covering this stock
Price Range
$18 - $29
Analyst target range
Coverage is limited with 11 analysts providing estimates, indicating moderate institutional interest for a large-cap stock. The consensus sentiment is neutral to bearish, as reflected in recent institutional ratings which are clustered around 'Hold', 'Neutral', 'Equal Weight', and 'Underweight', with no recent 'Buy' ratings cited. The average analyst revenue estimate for the upcoming period is $25.02 billion, with a tight range between $24.69 billion and $25.24 billion, suggesting strong agreement on the near-term revenue outlook. The target price range is not provided in the data, so the implied upside or downside cannot be calculated; however, the tight estimate range for revenue and EPS (average EPS estimate of $2.25) indicates analysts have a high degree of conviction in their near-term financial forecasts, though the lack of bullish ratings suggests limited enthusiasm for significant multiple expansion or outperformance.
Bulls vs Bears: KHC Investment Factors
The bull and bear cases for KHC are sharply divided between its underlying financial strength and its dismal growth trajectory. The bull case is anchored in compelling value metrics, robust cash generation, and a defensive profile, while the bear case focuses on persistent revenue declines, earnings volatility, and negative momentum. Currently, the bear side has stronger evidence, as reflected in the stock's consistent underperformance, negative analyst sentiment, and lack of a clear growth catalyst. The single most important tension in the investment debate is whether the company's strong free cash flow and low valuation can offset its inability to grow revenues in a mature, competitive industry. The resolution of this tension—specifically, a stabilization or return to modest top-line growth—would most dramatically change the thesis from a value trap to a legitimate turnaround story.
Bullish
- Strong Free Cash Flow Generation: The company generates substantial free cash flow, with TTM FCF of $3.66 billion. This provides significant financial flexibility to fund its 6.6% dividend yield, reduce debt, and repurchase shares, underpinning shareholder returns and balance sheet stability.
- Attractive Valuation Multiples: KHC trades at a Price-to-Sales ratio of 1.15x and an EV/Sales of 1.82x, which are low multiples typical of mature staples. This valuation is near the bottom of its historical range, suggesting market pessimism is fully priced in, creating a potential value opportunity.
- Defensive, Low-Beta Profile: With a beta of 0.076, the stock has moved independently of the broader market, falling 36.13% relative to the S&P 500 over the past year. This low correlation offers defensive characteristics and portfolio diversification, potentially limiting downside in a market downturn.
- Return to Quarterly Profitability: The latest Q4 2025 results show a return to core operational health with net income of $651 million, a net margin of 10.25%, and a gross margin of 32.61%. This contrasts sharply with the TTM net loss, indicating underlying earnings power remains intact.
Bearish
- Persistent Revenue Decline: Revenue growth is stagnant to negative, with Q4 2025 revenue of $6.35 billion representing a -3.38% year-over-year decline. This follows a volatile pattern, including a sharp drop in Q2 2025, highlighting persistent top-line challenges in a competitive market.
- Trailing Profitability & Margin Volatility: The company reported a trailing twelve-month net loss, with negative EPS of -$0.20 and a net margin of -23.44%. While the latest quarter was profitable, the TTM figures reflect significant one-time impairments and ongoing margin pressure from inflation and competition.
- Entrenched Downtrend & Weak Momentum: The stock is in a pronounced downtrend, down 11.14% over the past year and 6.90% over six months. Recent 3-month gains of 5.80% were erased by a -1.98% loss over the past month, indicating selling pressure persists and a durable floor has not been established.
- Negative Analyst Sentiment & Ownership Risk: Analyst consensus is neutral to bearish, clustered around 'Hold' and 'Underweight' ratings with no recent 'Buy' calls. Furthermore, news suggests Berkshire Hathaway's new CEO may reconsider its large stake, casting a shadow over ownership stability and confidence in the turnaround.
KHC Technical Analysis
The stock is entrenched in a pronounced downtrend, evidenced by a 1-year price change of -11.14% and a 6-month decline of -6.90%. As of the latest close of $22.82, the price sits near the lower end of its 52-week range, approximately 22% above its 52-week low of $21.035 and 22% below its high of $29.19, indicating the stock is in a value/oversold zone but has not yet found a durable floor. Recent momentum shows conflicting signals; the stock gained 5.80% over the past 3 months, suggesting a potential stabilization or relief rally, but this was entirely erased by a -1.98% loss over the past month, indicating the short-term recovery attempt has faltered and selling pressure persists. Key technical support is clearly defined at the 52-week low of $21.035, while resistance lies at the 52-week high of $29.19; a decisive break below support would signal a continuation of the bearish trend, whereas a sustained move above the recent trading range is needed to suggest a reversal. The stock exhibits extremely low market-correlated volatility with a beta of 0.076, meaning it has moved largely independently of the broader market, which fell 36.13% relative to the S&P 500 over the past year, highlighting its defensive but underperforming nature.
Beta
0.08
0.08x market volatility
Max Drawdown
-26.7%
Largest decline past year
52-Week Range
$21-$29
Price range past year
Annual Return
-13.3%
Cumulative gain past year
| Period | KHC Return | S&P 500 |
|---|---|---|
| 1m | -5.5% | -1.6% |
| 3m | +4.5% | +11.7% |
| 6m | -6.5% | +6.3% |
| 1y | -13.3% | +22.2% |
| ytd | -7.9% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
KHC Fundamental Analysis
Revenue growth is stagnant to slightly negative, with the most recent quarterly revenue of $6.354 billion representing a -3.38% year-over-year decline; this follows a volatile pattern across recent quarters, including a sharp revenue drop in Q2 2025, indicating persistent top-line challenges in a competitive packaged food market. The company is profitable on an operating basis but reported a trailing twelve-month net loss, as indicated by negative EPS of -$0.20 and a net margin of -23.44%; however, the latest quarter showed a return to profitability with net income of $651 million and a gross margin of 32.61%, suggesting underlying operations can generate earnings despite significant one-time impairments in prior periods. The balance sheet is relatively healthy with a moderate debt-to-equity ratio of 0.51 and a current ratio of 1.15, providing adequate liquidity; critically, the company generates substantial cash flow, with free cash flow over the trailing twelve months of $3.661 billion, which comfortably funds its dividend and provides flexibility for debt reduction or share repurchases, supporting its financial stability.
Quarterly Revenue
$6.4B
2025-12
Revenue YoY Growth
-0.03%
YoY Comparison
Gross Margin
+0.32%
Latest Quarter
Free Cash Flow
$3.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is KHC Overvalued?
Given the negative trailing net income (EPS of -$0.20), the primary valuation metric selected is the Price-to-Sales (PS) ratio. The stock trades at a trailing PS ratio of 1.15 and an Enterprise Value-to-Sales (EV/Sales) of 1.82, which are relatively low multiples typical of slow-growth, mature consumer staples companies. Compared to industry averages (data not available in the provided set), a PS ratio around 1.1x suggests KHC is likely trading at a discount to the packaged food sector, a discount that may be justified by its lack of revenue growth and margin volatility relative to more stable peers. Historically, the stock's own valuation has compressed; the current PS ratio of 1.15 is near the bottom of its multi-year range observed in the historical data (which shows PS ratios frequently above 4x in prior periods), indicating the market is currently pricing in very pessimistic expectations about future growth and profitability, presenting a potential value scenario if fundamentals stabilize.
PE
-4.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -461x~96x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-13.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on KHC's stagnant growth and earnings volatility. Revenue declined -3.38% YoY in Q4 2025, and the TTM net margin is deeply negative at -23.44%, primarily due to a massive $7.8B net loss in Q2 2025 from impairments. While the latest quarter showed profitability, this volatility creates uncertainty. The company's valuation discount (PS of 1.15x) is justified by this lack of growth, and continued revenue pressure could prevent multiple expansion. However, strong TTM FCF of $3.66B and a moderate D/E of 0.51 mitigate balance sheet risk.
Market & Competitive Risks are heightened by KHC's premium ownership uncertainty and sector headwinds. News suggests Berkshire Hathaway's new CEO may sell its large stake, removing a key support pillar and signaling a lack of confidence. The stock trades at a significant discount to its own historical valuation (PS frequently above 4x historically), but this compression may persist due to sector rotation away from slow-growth staples. Competitive disruption from private label and format innovation (e.g., portable pouches) threatens its iconic but aging brand portfolio. Its ultra-low beta of 0.076, while defensive, also means it fails to participate in market rallies, as evidenced by its -36% relative performance vs. the S&P 500 over the past year.
Worst-Case Scenario involves a perfect storm of fundamental deterioration and a loss of key support. This would entail: 1) Berkshire Hathaway executing a full stake sale, creating massive selling pressure; 2) another major impairment charge or guidance cut; 3) revenue declines accelerating beyond -3%; and 4) a dividend cut if FCF weakens. In this adverse scenario, the stock could re-test and break below its 52-week low of $21.035. Given the stock's 26.71% max drawdown and current price of $22.82, a realistic downside could be a -15% to -20% decline, pushing the stock toward the $18-$19 range, representing a loss of nearly $4 per share from current levels.
FAQ
The key risks are, in order of severity: 1) Fundamental Stagnation Risk: Persistent revenue decline (-3.38% YoY) and volatile profitability (TTM net margin -23.44%) may prevent any re-rating. 2) Ownership & Sentiment Risk: The potential for Berkshire Hathaway to sell its large stake, as suggested by recent news, could trigger a prolonged sell-off and loss of a key shareholder. 3) Competitive & Sector Risk: The company's mature brands face intense competition from private label and format innovation in a slow-growth industry. 4) Dividend Sustainability Risk: While currently well-supported by $3.66B in TTM FCF, a material decline in cash flow could pressure the high 6.6% yield.
The 12-month forecast for KHC is a range-bound outcome with a neutral bias. The base case (60% probability) sees the stock trading between $22 and $25, as it continues to generate cash and pay its dividend without growth catalysts. The bull case (20% probability) targets $27 to $29, requiring revenue stabilization and positive sentiment shifts. The bear case (20% probability) warns of a drop to $18 to $21 if fundamentals worsen or key support breaks. The most likely scenario is the base case, which assumes the current challenging operational environment persists. The average analyst EPS estimate for the upcoming period is $2.25, providing a forward P/E anchor of approximately 10.9x.
KHC is fairly valued relative to its current fundamentals but historically undervalued. Its primary valuation metric, the Price-to-Sales ratio, is 1.15x, which is low for a large-cap company and near the bottom of its own multi-year historical range (which has seen PS ratios above 4x). This discount is justified by its negative revenue growth and earnings volatility. Compared to likely packaged food peers, it likely trades at a discount. The market is pricing in very low expectations for future growth and profitability. Therefore, it is not overvalued, but it is also not screamingly undervalued without a visible path to improvement.
KHC is a good buy only for a specific type of investor: those seeking high current income from a defensive sector and who have a long-term, patient outlook. The stock offers a compelling 6.6% dividend yield supported by strong free cash flow and trades at a low Price-to-Sales multiple of 1.15x. However, it is not a good buy for growth-oriented investors, as revenue is declining (-3.38% YoY) and the stock is in a downtrend. The biggest risk is that it remains a 'value trap,' where the low valuation never improves due to persistent lack of growth. It could be a good buy on further weakness near its $21 support level for income seekers.
KHC is suitable only for long-term investment, with a suggested minimum holding period of 3-5 years. Its ultra-low beta of 0.076 means it has minimal correlation to short-term market moves, making it a poor trading vehicle. The investment thesis is based on collecting a high dividend while waiting for a potential turnaround or multiple expansion, which is a multi-year process. Short-term traders would be frustrated by its low volatility and lack of clear directional catalysts. For long-term, income-focused investors willing to accept low growth, the stock can serve as a defensive, yield-generating component of a portfolio.
